What Allot Ltd's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 5 | 13 |
| Total trades | 10 | 19 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 19 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Zohar Nadav | Director | Oct 22 | Grant / award · A | +13,512 | — | — | 58,884 |
| Reis David M | Director | Oct 22 | Grant / award · A | +23,768 | — | — | 185,768 |
| Makov Efrat | Director | Oct 22 | Grant / award · A | +13,512 | — | — | 43,198 |
| Levy Steven D | Director | Oct 22 | Grant / award · A | +13,512 | — | — | 45,661 |
| Kesten Raphael | Director | Oct 22 | Grant / award · A | +13,512 | — | — | 60,884 |
| Grossman Boaz | Senior Vice President R&D | Aug 28 | Open-market sale · S | −4,000 | $7.80 | −$31.2K | 182,000 |
| Grossman Boaz | Senior Vice President R&D | Aug 21 | Open-market sale · S | −6,000 | $7.45 | −$44.7K | 186,000 |
| Groner Gili | Chief Human Resources Officer | Aug 18 | Open-market sale · S | −26,666 | $7.86 | −$210K | 59,467 |
| Harari Eyal David | Chief Executive Officer | Aug 06 | Open-market sale · S | −29,111 | $7.64 | −$222K | 1,099,118 |
| Charash Inbar | General Counsel | Aug 03 | Open-market sale · S | −556 | $7.80 | −$4.34K | 28,008 |
| Shteiman Mark | Chief Product Officer | Jun 15 | Open-market sale · S | −2,000 | $7.50 | −$15K | 212,000 |
| Lelah Noam | SVP Customer Success & Ops | Jun 01 | Open-market sale · S | −21,000 | $8.48 | −$178K | 176,250 |
| Shteiman Mark | Chief Product Officer | May 22 | Open-market sale · S | −6,000 | $7.58 | −$45.5K | 214,000 |
| Shteiman Mark | Chief Product Officer | May 21 | Open-market sale · S | −5,000 | $7.39 | −$37K | 220,000 |
| Grossman Boaz | Senior Vice President R&D | May 20 | Open-market sale · S | −5,000 | $7.37 | −$36.9K | 192,000 |
| Shteiman Mark | Chief Product Officer | May 19 | Open-market sale · S | −5,000 | $7.32 | −$36.6K | 225,000 |
| Shteiman Mark | Chief Product Officer | May 18 | Open-market sale · S | −3,000 | $7.13 | −$21.4K | 230,000 |
| Harari Eyal David | Chief Executive Officer | May 12 | Grant / award · A | +72,259 | — | — | 1,128,229 |
| Charash Inbar | General Counsel | May 01 | Open-market sale · S | −556 | $7.40 | −$4.11K | 28,564 |
| Gemini Israel Funds Ltd. | 10% owner | Jun 07 | Open-market sale · S | −16,550 | $6.80 | −$113K | 1,702,679 |
Loading...
